by ericbarthe | Dec 4, 2023 | Markets, Products
… a reminder that potential risks can become a reality. According toย The Korea Times, South Korea’s Financial Supervisory Service is getting worried that autocallables were mis-sold to retail investors as they are facing potential $billions in losses, due...
by ericbarthe | Nov 6, 2023 | Markets, Products
Is accumulating post-nominal letters a sign of a competence? or a promise for future underperformance ? Regarding people, I cannot answer.Regarding Equity Indices… let’s take a look at a big commercial success: ๐๐๐๐ช๐ Index or the ๐๐๐ ๐๐๐ฅ๐๐ ๐ฒ๐ฌ ๐๐ช ๐๐ฅ. It is...
by ericbarthe | Nov 5, 2023 | Markets
The Q3 results of Roche disappointed the market. At 11:00am the spot is down 4.70%… The stock is now down 19% YTD and down 37% since January 2022.It is a big problem.As big as the total inventory of the Nestlรฉ-Roche-Novartis yield enhancement products in...
by ericbarthe | Aug 23, 2023 | Derivatives Theory and Practise, Products
Asset managers tend to classify structured products as โalternativesโ. That is rather a classification by default than the consequence of any analysis. They have cash, fixed income, equitiesโฆ and the rest, including structured products, is thrown into the alternatives...
by ericbarthe | Jul 20, 2023 | Derivatives Theory and Practise, Products
Banks and independent software companies offer optimisers / optimizers for structured products It is quite standard now for banks and software providers to offer an โoptimiserโ for structured products. Concretely, out of a universe of N stocks that you select, the...